文献速递瓣膜外科

美国主动脉瓣手术后肾衰竭的风险分析与结局

Risk Analysis and Outcomes of Postoperative Renal Failure After Aortic Valve Surgery in the United States.
PubMed 文献 · Ann Thorac Surg · 2019-09-05

基于STS数据库与Medicare数据链接,分析2008至2015年164727例主动脉瓣置换(伴或不伴CABG)患者,术后肾衰竭发生率为3.5%,其中63.3%需透析;术后肾衰竭与早期和晚期死亡率升高相关,需透析者风险更高。

要点

  • 术后肾衰竭发生率为3.5%,其中63.3%需新透析。
  • 术后肾衰竭患者手术死亡率为39.2%,透析者高于非透析者。
  • 术前肾功能差预测术后肾衰竭进展至透析及晚期死亡。

核心结论

  • 主动脉瓣置换伴或不伴CABG术后肾衰竭与早期和晚期死亡率升高相关,需新透析者风险进一步增加。
  • 术后肾衰竭一旦发生,术前肾功能不全不增加早期死亡风险,但预测晚期生存。
  • 术前肾功能与术后肾衰竭进展至透析相关。

研究设计与样本

  • 回顾性队列研究,链接STS数据库与Medicare索赔数据,纳入2008至2015年164727例主动脉瓣置换伴或不伴CABG患者。
  • 术后肾衰竭分为需新透析(RF-D)和不需新透析(RF no-D),采用Cox比例风险模型进行风险分析和结局评估。

主要发现

  • 164727例患者中3.5%发生术后肾衰竭,其中63.3%需透析。
  • 术后肾衰竭患者手术死亡率为39.2%,透析者46.1%高于非透析者26.1%(P < .0001)。
  • 与无术后肾衰竭相比,RF-D和RF no-D的早期(<30天)死亡风险HR分别为11.29(P < .0001)和8.03(P < .0001)。
  • 中位随访2.7年时,RF-D和RF no-D的晚期死亡风险HR分别为2.42(P < .0001)和1.69(P < .0001)。
  • 术前GFR <30 mL·min-1·1.73 m-2与GFR >60相比,早期死亡风险HR 0.48(P < .0001),晚期死亡风险HR 1.5(P < .0001)。

关键数值与推荐

  • 术后肾衰竭定义为需新透析(RF-D)或不需新透析(RF no-D)。
  • 长期进展至RF-D的预测因素:术前GFR <30(HR 13,P < .0001)、GFR 30-60(HR 2.47,P = .006)、胰岛素依赖型糖尿病(HR 1.96,P = .001)。

临床怎么用

  • 主动脉瓣置换术前应评估肾功能,识别术后肾衰竭高危患者。
  • 术后肾衰竭尤其需透析者应加强早期和长期随访管理。
  • 术前GFR <30患者术后肾衰竭进展至透析风险高,需重点监测。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative renal failure (RF) compromises early outcomes in cardiac surgery. In contrast, long-term survival and progression of RF after aortic valve replacement (AVR) with or without coronary artery bypass graft surgery (CABG) remain undefined. METHODS: From 2008 through 2015, records of AVR with or without CABG in The Society of Thoracic Surgeons database were linked to Medicare claims data. Postoperative RF was categorized as being with new dialysis (RF-D) or without new dialysis (RF no-D). Cox proportional hazards models were used to conduct a risk analysis and evaluate outcomes in this patient group. RESULTS: Of 164,727 patients undergoing AVR with or without CABG, 3.5% had postoperative RF, of whom 63.3% required dialysis. Operative mortality of postoperative RF was 39.2%, higher for dialysis than for no-dialysis patients (46.1% vs 26.1%, P < .0001). Both RF dialysis patients and no-dialysis patients had a higher early (less than 30-day) mortality risk (hazard ratio [HR] 11.29, P < .0001 and HR 8.03, P < .0001, respectively) compared with no postoperative RF. At a median follow-up of 2.7 years, RF-D and RF no-D remained relevant risk factors, however, with a lower magnitude of effect (HR 2.42, P < .0001, and HR 1.69, P < .0001, respectively). Preoperative glomerular filtration rate (GFR) less than 30 mL · min-1 · 1.73 m-2 had a lower early mortality risk (HR 0.48, P < .0001) but higher late mortality risk (HR 1.5, P < .0001) compared with GFR greater than 60. Predictors for long-term progression to RF-D included preoperative GFR less than 30 (HR 13, P < .0001), GFR 30 to 60 (HR 2.47, P = .006), and insulin-dependent diabetes mellitus (HR 1.96, P = .001). CONCLUSIONS: Postoperative RF after AVR with or without CABG was associated with higher early and late mortality, which further increased with a new requirement for dialysis. Once postoperative RF develops, preoperative renal dysfunction does not increase early mortality; however, it predicts late survival. Preoperative renal function is associated with progression of postoperative RF to dialysis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Caceres Polo M, Thibault D, Thourani VH, et al. Risk Analysis and Outcomes of Postoperative Renal Failure After Aortic Valve Surgery in the United States. Ann Thorac Surg. 2019. PMID: 31494138. doi:10.1016/j.athoracsur.2019.07.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。